945 related articles for article (PubMed ID: 24127854)
1. pH and thermo dual-stimuli-responsive drug carrier based on mesoporous silica nanoparticles encapsulated in a copolymer-lipid bilayer.
Wu X; Wang Z; Zhu D; Zong S; Yang L; Zhong Y; Cui Y
ACS Appl Mater Interfaces; 2013 Nov; 5(21):10895-903. PubMed ID: 24127854
[TBL] [Abstract][Full Text] [Related]
2. In vivo distribution and antitumor activity of doxorubicin-loaded N-isopropylacrylamide-co-methacrylic acid coated mesoporous silica nanoparticles and safety evaluation.
Chen Y; Yang W; Chang B; Hu H; Fang X; Sha X
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):406-12. PubMed ID: 23816639
[TBL] [Abstract][Full Text] [Related]
3. Natural gelatin capped mesoporous silica nanoparticles for intracellular acid-triggered drug delivery.
Zou Z; He D; He X; Wang K; Yang X; Qing Z; Zhou Q
Langmuir; 2013 Oct; 29(41):12804-10. PubMed ID: 24073830
[TBL] [Abstract][Full Text] [Related]
4. Facile synthesis of pH sensitive polymer-coated mesoporous silica nanoparticles and their application in drug delivery.
Tang H; Guo J; Sun Y; Chang B; Ren Q; Yang W
Int J Pharm; 2011 Dec; 421(2):388-96. PubMed ID: 22001840
[TBL] [Abstract][Full Text] [Related]
5. pH-sensitive poly(glutamic acid) grafted mesoporous silica nanoparticles for drug delivery.
Zheng J; Tian X; Sun Y; Lu D; Yang W
Int J Pharm; 2013 Jun; 450(1-2):296-303. PubMed ID: 23598077
[TBL] [Abstract][Full Text] [Related]
6. Ionic and thermo-switchable polymer-masked mesoporous silica drug-nanocarrier: High drug loading capacity at 10°C and fast drug release completion at 40°C.
Eltohamy M; Seo JW; Hwang JY; Jang WC; Kim HW; Shin US
Colloids Surf B Biointerfaces; 2016 Aug; 144():229-237. PubMed ID: 27092438
[TBL] [Abstract][Full Text] [Related]
7. Thermal and pH responsive polymer-tethered multifunctional magnetic nanoparticles for targeted delivery of anticancer drug.
Sahoo B; Devi KS; Banerjee R; Maiti TK; Pramanik P; Dhara D
ACS Appl Mater Interfaces; 2013 May; 5(9):3884-93. PubMed ID: 23551195
[TBL] [Abstract][Full Text] [Related]
8. pH-controllable drug carrier with SERS activity for targeting cancer cells.
Fang W; Wang Z; Zong S; Chen H; Zhu D; Zhong Y; Cui Y
Biosens Bioelectron; 2014 Jul; 57():10-5. PubMed ID: 24525050
[TBL] [Abstract][Full Text] [Related]
9. pH-responsive composite microspheres based on magnetic mesoporous silica nanoparticle for drug delivery.
Wen H; Guo J; Chang B; Yang W
Eur J Pharm Biopharm; 2013 May; 84(1):91-8. PubMed ID: 23207322
[TBL] [Abstract][Full Text] [Related]
10. Enzyme and Thermal Dual Responsive Amphiphilic Polymer Core-Shell Nanoparticle for Doxorubicin Delivery to Cancer Cells.
Kashyap S; Singh N; Surnar B; Jayakannan M
Biomacromolecules; 2016 Jan; 17(1):384-98. PubMed ID: 26652038
[TBL] [Abstract][Full Text] [Related]
11. Embedding fluorescent mesoporous silica nanoparticles into biocompatible nanogels for tumor cell imaging and thermo/pH-sensitive in vitro drug release.
Gui R; Wang Y; Sun J
Colloids Surf B Biointerfaces; 2014 Apr; 116():518-25. PubMed ID: 24576821
[TBL] [Abstract][Full Text] [Related]
12. Thermo/pH dual-stimuli-responsive drug delivery for chemo-/photothermal therapy monitored by cell imaging.
Shu Y; Song R; Zheng A; Huang J; Chen M; Wang J
Talanta; 2018 May; 181():278-285. PubMed ID: 29426513
[TBL] [Abstract][Full Text] [Related]
13. Thermo-responsive mesoporous silica/lipid bilayer hybrid nanoparticles for doxorubicin on-demand delivery and reduced premature release.
Zhang Q; Chen X; Shi H; Dong G; Zhou M; Wang T; Xin H
Colloids Surf B Biointerfaces; 2017 Dec; 160():527-534. PubMed ID: 29024917
[TBL] [Abstract][Full Text] [Related]
14. Temperature-sensitive copolymer-coated fluorescent mesoporous silica nanoparticles as a reactive oxygen species activated drug delivery system.
Yu F; Wu H; Tang Y; Xu Y; Qian X; Zhu W
Int J Pharm; 2018 Jan; 536(1):11-20. PubMed ID: 29146540
[TBL] [Abstract][Full Text] [Related]
15. Dual stimuli-responsive poly(N-isopropylacrylamide)-b-poly(L-histidine) chimeric materials for the controlled delivery of doxorubicin into liver carcinoma.
Johnson RP; Jeong YI; John JV; Chung CW; Kang DH; Selvaraj M; Suh H; Kim I
Biomacromolecules; 2013 May; 14(5):1434-43. PubMed ID: 23627834
[TBL] [Abstract][Full Text] [Related]
16. Co-delivery of erlotinib and doxorubicin by pH-sensitive charge conversion nanocarrier for synergistic therapy.
He Y; Su Z; Xue L; Xu H; Zhang C
J Control Release; 2016 May; 229():80-92. PubMed ID: 26945977
[TBL] [Abstract][Full Text] [Related]
17. Dual-responsive controlled drug delivery based on ionically assembled nanoparticles.
Cui W; Lu X; Cui K; Niu L; Wei Y; Lu Q
Langmuir; 2012 Jun; 28(25):9413-20. PubMed ID: 22624601
[TBL] [Abstract][Full Text] [Related]
18. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery.
Ma X; Zhao Y; Ng KW; Zhao Y
Chemistry; 2013 Nov; 19(46):15593-603. PubMed ID: 24123533
[TBL] [Abstract][Full Text] [Related]
19. P(EO-co-LLA) functionalized Fe3O4@mSiO2 nanocomposites for thermo/pH responsive drug controlled release and hyperthermia.
Guo W; Yang C; Lin H; Qu F
Dalton Trans; 2014 Dec; 43(48):18056-65. PubMed ID: 25353400
[TBL] [Abstract][Full Text] [Related]
20. Intracellular pH-Triggered, Targeted Drug Delivery to Cancer Cells by Multifunctional Envelope-Type Mesoporous Silica Nanocontainers.
Yang K; Luo H; Zeng M; Jiang Y; Li J; Fu X
ACS Appl Mater Interfaces; 2015 Aug; 7(31):17399-407. PubMed ID: 26196506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
